Index | Solactive L&G Global Thematic |
Investment focus | Equity, World, Social/Environmental |
Fund size | GBP 4 m |
Total expense ratio | 0.60% p.a. |
Replication | Physical (Optimized sampling) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | Yes |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 13.47% |
Inception/ Listing Date | 1 September 2022 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Legal & General (LGIM) |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
Investment Advisor | Legal & General Investment Management Limited |
Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
Revision Company | EY |
Fiscal Year End | 30 June |
Swiss representative | State Street |
Swiss paying agent | State Street Bank International GmbH, München, Zweigniederlassung Zürich |
Germany | Unknown |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | - |
Collateral manager | BNY Mellon Fund Services (Ireland) Limited |
Securities lending | No |
Securities lending counterparty |
HD Hyundai Electric Co., Ltd. | 1.92% |
Sumitomo Electric Industries Ltd. | 1.30% |
Tesla | 1.14% |
Siemens Energy AG | 1.03% |
Chugai Pharmaceutical Co., Ltd. | 0.99% |
Swedish Orphan Biovitrum AB | 0.97% |
Vertex Pharmaceuticals, Inc. | 0.94% |
Alnylam Pharmaceuticals | 0.90% |
United Therapeutics Corp. | 0.88% |
TDK Corp. | 0.84% |
YTD | +3.80% |
1 month | +0.67% |
3 months | +3.44% |
6 months | +2.04% |
1 year | +10.81% |
3 years | - |
5 years | - |
Since inception (MAX) | +4.28% |
2023 | +6.36% |
2022 | - |
2021 | - |
2020 | - |
Volatility 1 year | 13.47% |
Volatility 3 years | - |
Volatility 5 years | - |
Return per risk 1 year | 0.80 |
Return per risk 3 years | - |
Return per risk 5 years | - |
Maximum drawdown 1 year | -7.99% |
Maximum drawdown 3 years | - |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -17.43% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | THNZ | - - | - - | - |
Borsa Italiana | EUR | THMZ | THMZ IM THNZEUIV | THMZ.MI | Flow Traders B.V. |
London Stock Exchange | GBX | THMG | THMG LN | THMG.L | Flow Traders B.V. |
London Stock Exchange | USD | THMZ | THMZ LN | THMZ.L | Flow Traders B.V. |
SIX Swiss Exchange | CHF | THMZ | THMZ SW THNZEUIV | THMZ.S | Flow Traders B.V. |
XETRA | EUR | THNZ | THNZ GY THNZEUIV | THNZ.DE | Flow Traders B.V. |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Healthcare Innovation UCITS ETF | 989 | 0.40% p.a. | Accumulating | Sampling |
Amundi MSCI Disruptive Technology ESG Screened UCITS ETF Acc | 145 | 0.45% p.a. | Accumulating | Full replication |
WisdomTree Megatrends UCITS ETF USD | 56 | 0.50% p.a. | Accumulating | Full replication |
Xtrackers MSCI Innovation UCITS ETF 1C | 8 | 0.30% p.a. | Accumulating | Full replication |
VanEck Genomics and Healthcare Innovators UCITS ETF A | 5 | 0.35% p.a. | Accumulating | Full replication |